TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Clinical trial NCT06533826 · RECRUITING
Trial details
- NCT number
- NCT06533826
- Sponsor
- Ana C Garrido-Castro, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-29
- Primary completion
- 2028-01-01
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.